Try it
PSM · Epidemiology: phase III trial
Sample itemA new antidiabetic drug that has shown acceptable safety and some effect in earlier studies is now compared with standard therapy in a large multicentre randomised trial of several thousand patients, mainly to confirm efficacy and detect adverse effects before licensing. Which phase is this?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Phase III
Phase III trials are large randomised comparisons with standard treatment that confirm efficacy and monitor adverse effects, and their results support a licensing application. Phase I tests safety and dose in a few volunteers, phase II tests efficacy in a limited patient group, and phase IV is post-marketing surveillance.
Option by option
A. Phase III (correct)
Correct. A large randomised comparison with standard care before licensing is phase III.
B. Phase IV
Phase IV occurs after marketing to detect rare adverse effects.
C. Phase II
Phase II studies efficacy and dose in a limited number of patients.
D. Phase I
Phase I involves a small number of volunteers to study safety and dose.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More PSM questions
- BiostatisticsOf 200 people who truly have a disease, a screening test is positive in 180. What is the…
- Environmental healthAfter one hour of contact time, what residual free chlorine level is generally recommend…
- EpidemiologyWhich study design is the most efficient for investigating risk factors of a rare disease?
- BiostatisticsIn hypothesis testing, a Type I error is: